# Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

> **NCT04983823** · NA · RECRUITING · sponsor: **Baker Heart and Diabetes Institute** · enrollment: 820 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** Heart Failure intervention (Cardiac COVID Disease Management Plan (CC-DMP)
- **OTHER:** Usual care

## Key facts

- **NCT ID:** NCT04983823
- **Lead sponsor:** Baker Heart and Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-18
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 820 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04983823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04983823, "Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04983823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*